For: | Tiwari A, Saraf S, Verma A, Panda PK, Jain SK. Novel targeting approaches and signaling pathways of colorectal cancer: An insight. World J Gastroenterol 2018; 24(39): 4428-4435 [PMID: 30357011 DOI: 10.3748/wjg.v24.i39.4428] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i39/4428.htm |
Number | Citing Articles |
1 |
Zahra Koveitypour, Farnoush Panahi, Mehrdad Vakilian, Maryam Peymani, Farzad Seyed Forootan, Mohammad Hossein Nasr Esfahani, Kamran Ghaedi. Signaling pathways involved in colorectal cancer progression. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0361-4
|
2 |
Feng Zhang, Song Qiao. Research Progress on the Relationship Between Inflammation and Colorectal Cancer. Annals of Gastroenterological Surgery 2022; 6(2): 204 doi: 10.1002/ags3.12517
|
3 |
Meng Zhang, Zhongyi Tao, Lijuan Gao, Fengyang Chen, Yiping Ye, Shifang Xu, Wenkang Huang, Xiaoyu Li. Toosendanin inhibits colorectal cancer cell growth through the Hedgehog pathway by targeting Shh. Drug Development Research 2022; 83(5): 1201 doi: 10.1002/ddr.21951
|
4 |
Roya Abedizadeh, Fateme Majidi, Hamid Reza Khorasani, Hassan Abedi, Davood Sabour. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer and Metastasis Reviews 2024; 43(2): 729 doi: 10.1007/s10555-023-10158-3
|
5 |
Manasi Sawant, Martha Baydoun, Colette Creusy, Magali Chabé, Eric Viscogliosi, Gabriela Certad, Sadia Benamrouz-Vanneste. Cryptosporidium and Colon Cancer: Cause or Consequence?. Microorganisms 2020; 8(11): 1665 doi: 10.3390/microorganisms8111665
|
6 |
Yosuke Sato, Yu Fu, Hong Liu, Min Young Lee, Michael H. Shaw. Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08974-3
|
7 |
Dan Hu, Ruo Meng, Thi Nguyen, Ok Chai, Byung Park, Ju-Seog Lee, Soo Kim. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway. Molecular Medicine Reports 2022; 27(1) doi: 10.3892/mmr.2022.12898
|
8 |
Sara Sommariva, Silvia Berra, Giorgia Biddau, Giacomo Caviglia, Federico Benvenuto, Michele Piana. In-silico modelling of the mitogen-activated protein kinase (MAPK) pathway in colorectal cancer: mutations and targeted therapy. Frontiers in Systems Biology 2023; 3 doi: 10.3389/fsysb.2023.1207898
|
9 |
Faris Alrumaihi, Masood Alam Khan, Ali Yousif Babiker, Mohammed Alsaweed, Faizul Azam, Khaled S. Allemailem, Ahmad A. Almatroudi, Syed Rizwan Ahamad, Naif AlSuhaymi, Mahdi H. Alsugoor, Ahmed N. Algefary, Arif Khan. The Effect of Liposomal Diallyl Disulfide and Oxaliplatin on Proliferation of Colorectal Cancer Cells: In Vitro and In Silico Analysis. Pharmaceutics 2022; 14(2): 236 doi: 10.3390/pharmaceutics14020236
|
10 |
Mingxing Ma, Li Li, He Chen, Yong Feng. Oxytocin Inhibition of Metastatic Colorectal Cancer by Suppressing the Expression of Fibroblast Activation Protein-α. Frontiers in Neuroscience 2019; 13 doi: 10.3389/fnins.2019.01317
|
11 |
Pritish Kumar Panda, Amit Verma, Shivani Saraf, Sarjana Raikwar, Pooja Da Bidla, Sanjay K. Jain. Polymeric Nanosystems. 2023; : 13 doi: 10.1016/B978-0-323-85656-0.00017-6
|
12 |
Yuan-Hong Xie, Ying-Xuan Chen, Jing-Yuan Fang. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0116-z
|
13 |
Zhe Huang, Mingli Yang. Molecular Network of Colorectal Cancer and Current Therapeutic Options. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.852927
|
14 |
Vemula Sarojamma, Ramakrishna Vadde.
Naringenin in the Prevention of Colon Cancer: An Updated Review
. Onco Therapeutics 2022; 9(2): 25 doi: 10.1615/OncoTherap.2022044893
|
15 |
Hilal NAKKAŞ, Tuba ÖZDEMİR SANCI, Beyza Ecem ÖZ BEDİR, Emine TERZİ. Kolorektal Kanserde Rapamisin ve Vemurafenib’in Apoptotik Etkilerinin Karşılaştırılması. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2023; 49(3): 331 doi: 10.32708/uutfd.1376556
|
16 |
Yizhou Yao, Xuchao Wang, Diyuan Zhou, Hao Li, Huan Qian, Jiawen Zhang, Linhua Jiang, Bin Wang, Qi Lin, Xinguo Zhu. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. Aging 2020; 12(13): 13059 doi: 10.18632/aging.103393
|
17 |
Dimitrios Tsounis, Vassiliki Villiotou, Angeliki Melpidou, Chara Pantsiou, Alexandra Argyrou, Charis Giannopoulou, Adriani Grigoratou, Dimitra Rontogianni, Gerassimos J Mantzaris, George Papatheodoridis. Oxidative imbalance increases the risk for colonic polyp and colorectal cancer development. World Journal of Gastrointestinal Oncology 2022; 14(11): 2208-2223 doi: 10.4251/wjgo.v14.i11.2208
|
18 |
Jaqueline Barbosa de Souza, Maria Carolina Accioly Brelaz-de-Castro, Isabella Macário Ferro Cavalcanti. Strategies for the treatment of colorectal cancer caused by gut microbiota. Life Sciences 2022; 290: 120202 doi: 10.1016/j.lfs.2021.120202
|
19 |
Ankita Tiwari, Virendra Gajbhiye, Ankit Jain, Amit Verma, Aazam Shaikh, Rajesh Salve, Sanjay K. Jain. Hyaluronic acid functionalized liposomes embedded in biodegradable beads for duo drugs delivery to oxaliplatin-resistant colon cancer. Journal of Drug Delivery Science and Technology 2022; 77: 103891 doi: 10.1016/j.jddst.2022.103891
|
20 |
Faris Alrumaihi, Masood Alam Khan, Ali Yousif Babiker, Mohammed Alsaweed, Faizul Azam, Khaled S. Allemailem, Ahmad A. Almatroudi, Syed Rizwan Ahamad, Mahdi H. Alsugoor, Khloud Nawaf Alharbi, Nahlah Makki Almansour, Arif Khan. Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis. Molecules 2022; 27(7): 2192 doi: 10.3390/molecules27072192
|
21 |
Imran Khan, Sadaf Mahfooz, Mohammad Faisal, Abdulrahman A. Alatar, Irfan A. Ansari. Andrographolide Induces Apoptosis and Cell Cycle Arrest through Inhibition of Aberrant Hedgehog Signaling Pathway in Colon Cancer Cells. Nutrition and Cancer 2021; 73(11-12): 2428 doi: 10.1080/01635581.2020.1828942
|
22 |
Mohamed Adil, Anandraj K. Vaithy.k, Ashok Kumar Pandurangan, Mohammad Waseem, Neesar Ahmed. Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer. Advances in Medical Diagnosis, Treatment, and Care 2021; : 24 doi: 10.4018/978-1-7998-3580-6.ch002
|
23 |
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava. Targeting Signaling Pathways in Solid Tumors - Part A. International Review of Cell and Molecular Biology 2024; 385: 41 doi: 10.1016/bs.ircmb.2023.11.006
|
24 |
Mengyuan Cao, Yunmeng Wang, Guige Lu, Haoran Qi, Peiyu Li, Xiaoshuo Dai, Jing Lu. Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer. Current Issues in Molecular Biology 2022; 44(10): 4447 doi: 10.3390/cimb44100305
|
25 |
Amin Sepehr, Shadi Aghamohammad, Roya Ghanavati, Malihe Talebi, Mohammad Reza Pourshafie*, Mahdi Rohani. Role of Native Probiotic Lactobacillus Species via TGF-β Signaling Pathway Modulation in CRC. Iranian Biomedical Journal 2024; 28(4): 168 doi: 10.61186/ibj.4012
|
26 |
Yanhui Si, Lei Li, Weiwei Zhang, Qiling Liu, Baochi Liu. GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/β‑catenin and Notch signalling pathways. Oncology Reports 2022; 48(4) doi: 10.3892/or.2022.8397
|
27 |
Sridhar Muthusami, Ilangovan Ramachandran, Sneha Krishnamoorthy, Yuvaraj Sambandam, Satish Ramalingam, Lurdes Queimado, Gautam Chaudhuri, Ileng Kumaran Ramachandran. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(1): 67 doi: 10.2174/1871530320666200917112802
|
28 |
Yongkang An, Shuangxi Zhang, Jing Zhang, Qing Yin, Haitao Han, Fang Wu, Xiangan Zhang. <p>Overexpression of lncRNA NLIPMT Inhibits Colorectal Cancer Cell Migration and Invasion by Downregulating TGF-β1</p>. Cancer Management and Research 2020; : 6045 doi: 10.2147/CMAR.S247764
|
29 |
Mohammad Housini, Begum Dariya, Nadia Ahmed, Alyssa Stevens, Hope Fiadjoe, Ganji Purnachandra Nagaraju, Riyaz Basha. Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. Gene 2024; 892: 147857 doi: 10.1016/j.gene.2023.147857
|
30 |
Jinwen Chen, Wei Chen, Xiaoyu Li, Yiping Ye, Wenkang Huang, Lijuan Gao, Meng Zhang. CBC-1 as a Cynanbungeigenin C derivative inhibits the growth of colorectal cancer through targeting Hedgehog pathway component GLI 1. Steroids 2024; 206: 109421 doi: 10.1016/j.steroids.2024.109421
|
31 |
Ankita Tiwari, Sanjay K. Jain. Curcumin Based Drug Delivery Systems for Cancer Therapy. Current Pharmaceutical Design 2020; 26(42): 5430 doi: 10.2174/1381612826666200429095503
|
32 |
Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Frontiers in Nanotechnology 2021; 3 doi: 10.3389/fnano.2021.644023
|
33 |
Hong-Chieh Tsai, Han-Hsing Tsou, Chun-Chi Lin, Shao-Chen Chen, Hsiao-Wei Cheng, Tsung-Yun Liu, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Shih-Ching Chang, Hao-Wei Teng, Hsiang-Tsui Wang. Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92035-z
|
34 |
Wolfgang Eberhardt, Kristina Haeussler, Usman Nasrullah, Josef Pfeilschifter. Multifaceted Roles of TRIM Proteins in Colorectal Carcinoma. International Journal of Molecular Sciences 2020; 21(20): 7532 doi: 10.3390/ijms21207532
|
35 |
Eirini Tsirvouli, Vasundra Touré, Barbara Niederdorfer, Miguel Vázquez, Åsmund Flobak, Martin Kuiper. A Middle-Out Modeling Strategy to Extend a Colon Cancer Logical Model Improves Drug Synergy Predictions in Epithelial-Derived Cancer Cell Lines. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.502573
|
36 |
Prafulla Sabale, Suchita Waghmare, Lata Potey, Pramod Khedekar, Vidya Sabale, Nilesh Rarokar, Rupesh Chikhale, Rohini Palekar. Colorectal Cancer. 2024; : 489 doi: 10.1016/B978-0-443-13870-6.00017-9
|
37 |
Su Wen, Xueqing Huang, Liping Xiong, Hao Zeng, Shuang Wu, Kangli An, Jing Bai, Zhipeng Zhou, Tiejun Yin. WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells. Molecular and Cellular Biochemistry 2024; 479(12): 3341 doi: 10.1007/s11010-024-04937-x
|
38 |
Yangyang Xie, Xiaotong Li, Jingyi Wu, Huiling Zeng, Hamza Boucetta, Binru Wang, Pei Yang, Wei He. CAR-T cells for cancer immunotherapy. Chinese Chemical Letters 2023; 34(9): 108202 doi: 10.1016/j.cclet.2023.108202
|
39 |
Flaviana Marzano, Mariano Francesco Caratozzolo, Graziano Pesole, Elisabetta Sbisà, Apollonia Tullo. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines 2021; 9(3): 241 doi: 10.3390/biomedicines9030241
|
40 |
|
41 |
Manuel Bernabé‐García, Elena Martínez‐Balsalobre, Diana García‐Moreno, Jesús García‐Castillo, Beatriz Revilla‐Nuin, Elena Blanco‐Alcaina, Victoriano Mulero, Francisca Alcaraz‐Pérez, María L. Cayuela. Telomerase reverse transcriptase activates transcription ofmiR500Ato inhibit Hedgehog signalling and promote cell invasiveness. Molecular Oncology 2021; 15(7): 1818 doi: 10.1002/1878-0261.12943
|
42 |
Petru Radu, Mihai Zurzu, Anca Tigora, Vlad Paic, Mircea Bratucu, Dragos Garofil, Valeriu Surlin, Alexandru Claudiu Munteanu, Ionut Simion Coman, Florian Popa, Victor Strambu, Sandu Ramboiu. The Impact of Cancer Stem Cells in Colorectal Cancer. International Journal of Molecular Sciences 2024; 25(8): 4140 doi: 10.3390/ijms25084140
|
43 |
Saeed Noorolyai, Elham Baghbani, Dariush Shanehbandi, Vahid Khaze Shahgoli, Amir Baghbanzadeh Kojabad, Behzad Mansoori, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Behzad Baradaran. miR‐146a‐5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway. Advanced Pharmaceutical Bulletin 2020; 11(4): 755 doi: 10.34172/apb.2021.085
|
44 |
Aliki Vaia Rompou, Garyfalia Bletsa, Dimitris Tsakogiannis, Stamatios Theocharis, Panteleimon Vassiliu, Nick Danias. An Updated Review of Resistin and Colorectal Cancer. Cureus 2024; doi: 10.7759/cureus.65403
|
45 |
Xuan Yu, Yongfu Shao, Haotian Dong, Xinjun Zhang, Guoliang Ye. Biological function and potential application of PANoptosis-related genes in colorectal carcinogenesis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71625-7
|
46 |
Pooja Das Bidla, Pritish K. Panda, Amit Verma, Sarjana Raikwar, Sanjay K. Jain. Applications of Nanovesicular Drug Delivery. 2022; : 253 doi: 10.1016/B978-0-323-91865-7.00003-1
|
47 |
Yi-Hsuan Huang, Peng-Chan Lin, Wu-Chou Su, Ren-Hao Chan, Po-Chuan Chen, Bo-Wen Lin, Meng-Ru Shen, Shang-Hung Chen, Yu-Min Yeh. Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer. Diagnostics 2021; 11(12): 2308 doi: 10.3390/diagnostics11122308
|
48 |
Suman Kumar Ray, Sukhes Mukherjee. Altered Expression of TRIM Proteins - Inimical Outcome and
Inimitable Oncogenic Function in Breast Cancer with Diverse
Carcinogenic Hallmarks. Current Molecular Medicine 2023; 23(1): 44 doi: 10.2174/1566524022666220111122450
|
49 |
Nerethika Ravichandiran, Muneesh Kumar Barman, Sai Tejaswi Lavuri, Manjita Srivastava, Shalini Sakthivel, Meenakshi Singh, Kailash Chand, Subash C. Sonkar, Prudhvilal Bhukya. Handbook of Research on Advancements in Cancer Therapeutics. Advances in Medical Diagnosis, Treatment, and Care 2021; : 433 doi: 10.4018/978-1-7998-6530-8.ch015
|
50 |
Chiara Tramontano, João Pedro Martins, Luca De Stefano, Marianna Kemell, Alexandra Correia, Monica Terracciano, Nicola Borbone, Ilaria Rea, Hélder A. Santos. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells. Advanced Healthcare Materials 2023; 12(6) doi: 10.1002/adhm.202202672
|
51 |
Vikas Chandra, Ashutosh Tiwari, Rajat Pratap Singh, Kartiki V. Desai. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; : 143 doi: 10.1007/978-3-030-72702-4_8
|
52 |
Batoul Kavyani, Fereshteh Saffari, Ali Afgar, Sajjad Kavyani, Masoud Rezaie, Fatemeh Sharifi, Roya Ahmadrajabi. Gallocin-derived Engineered Peptides Targeting EGFR and VEGFR in
Colorectal Cancer: A Bioinformatic Approach. Current Topics in Medicinal Chemistry 2024; 24(18): 1599 doi: 10.2174/0115680266295587240522050712
|
53 |
Pritish Kumar Panda, Shivani Saraf, Amit Verma, Ankit Jain, Pooja Das Bidla, Sarjana Raikwar, Priyanka Kumari, Sanjay K. Jain. Role of Vitamins in Therapeutic and Targeting Approaches for Prostate Cancer: An Overview. Current Drug Targets 2024; 25(14): 934 doi: 10.2174/0113894501314558240822082557
|
54 |
Amit Verma, Pritish Kumar Panda, Sanjay K. Jain. Advanced Nanoformulations. 2023; : 241 doi: 10.1016/B978-0-323-85785-7.00007-3
|
55 |
Ankita Tiwari, Shivani Saraf, Ankit Jain, Pritish K. Panda, Amit Verma, Sanjay K. Jain. Basics to advances in nanotherapy of colorectal cancer. Drug Delivery and Translational Research 2020; 10(2): 319 doi: 10.1007/s13346-019-00680-9
|
56 |
Neha Merchant, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 1 doi: 10.1007/978-981-15-5471-1_1
|
57 |
Neha Shree Maurya, Ashutosh Mani. Navigating Molecular Pathways: An Update on Drugs in Colorectal
Cancer Treatment. Current Topics in Medicinal Chemistry 2023; 23(30): 2821 doi: 10.2174/1568026623666230614165548
|
58 |
Maged. W. Helmy, Asser I. Ghoneim, Mohamed A. Katary, Rana K. Elmahdy. The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis. Molecular Biology Reports 2020; 47(3): 2217 doi: 10.1007/s11033-020-05327-4
|
59 |
Menglin Xu, Xinyu Shao, Haoran Li, Zhengrong Zhang, Chunli Zhou, Zhengwu Cheng. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77182-z
|
60 |
Ji Di, Jia Luo, Rong Wang, Sheng-Yan Jin, Sheng-Wu Zhang, Bo Jiang. Curcumin-Coated Poly(lactic-co-glycolic acid) Nanoparticles Affect Colorectal Cancer Cells Growth by Regulating Notch Signaling Pathway. Science of Advanced Materials 2022; 14(4): 718 doi: 10.1166/sam.2022.4250
|
61 |
Tian Fang, Tingting Liang, Yizhuo Wang, Haitao Wu, Shuhan Liu, Linying Xie, Jiaying Liang, Chang Wang, Yehui Tan. Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01864-9
|
62 |
Aldona Kasprzak. Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia. International Journal of Molecular Sciences 2023; 24(4): 3665 doi: 10.3390/ijms24043665
|
63 |
Wenwen Wang, Zhongyi Tao, Linglan Tu, Wenkang Huang, Yiping Ye, Lijuan Gao, Xiaoyu Li. Diterpenoids from Scutellaria barbata D. Don Exert the Antiproliferative Effect on Colorectal Cancer Cells Via Hedgehog Signaling Pathway. Pharmacognosy Magazine 2024; 20(3): 877 doi: 10.1177/09731296241234714
|
64 |
Shiv Kumar Prajapati, Ankit Jain, Aakanchha Jain, Sourabh Jain. Biodegradable polymers and constructs: A novel approach in drug delivery. European Polymer Journal 2019; 120: 109191 doi: 10.1016/j.eurpolymj.2019.08.018
|